| 中文名 | 2H-环戊并[B]呋喃-2-酮,5-(苯甲酰氧基)-4-[(1E)-3,3-二氟-4-苯氧基-丁烯-1-基]六氢-,(3AR,4R,5R,6AS)-(...) |
|---|---|
| 英文名 | [(3aR,4R,5R,6aS)-4-(3,3-difluoro-4-phenoxybut-1-enyl)-2-oxo-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] benzoate |
| 中文别名 |
前列腺素杂质38
3,3-二氟-4-苯氧基-丁烯 他氟前列素杂质22 (3,4R,5R,6AS)-5-(苯甲酰氧基)-4-[(1E)-3,3-二氟-4-苯氧基-1-丁烯-1-基]六氢2H-环戊烷并[B]呋喃-2-酮 2H-环戊并[B]呋喃-2-酮,5-(苯甲酰氧基) (3,4R,5R,6AS)- 5-(苯甲酰氧基)-4-[(1E)-3,3-二氟-4-苯氧基-丁烯-1-基]六氢-2H-环戊并[B]呋喃-2-酮 他氟前列素中间体1 他氟前列素杂质29 (3,4R,5R,6AS)-5-(苯甲酰氧基)-4-[(1E)-3,3-二氟-4-苯氧基-1-丁烯基]六氢-2H-环戊二烯并[B]呋喃-2-酮 批发209-7 (3,4R,5R,6AS)-4-((E)-3,3-二氟-4-苯氧基丁-1-烯-1-基)-2-氧代六氢-2H-环戊二烯并[B]呋喃-5-基苯甲酸酯 中间体209-7 2H-环戊并[B]呋喃-2-酮,5-(苯甲酰氧基)-4-[(1E)-3,3-二氟-4-苯氧基-丁烯-1-基]六氢-,(3,4R,5R,6AS)-(...) 拉坦前列腺素杂质21 |
| 英文别名 |
(3aR,4R,5R,6aS)-4-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
Tafluprost int (3,4R,5R,6aS)-4-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-2-oxohexahydro-2H-cy 2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-, (3,4R,5R,6aS) (1S,5R,6R,7R)-2-oxa-7-benzoyloxy-6-[(1E)-3,3-difluoro-4-phenoxy-1-butenyl]bicyclo[3.3.0]octan-3-one (3,4R,5R,6aS)-5-(Benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-butenyl]hexahydro-2H-cyclopenta[b]furan-2-one (3,4R,5R,6aS)-4-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]fur (3,4R,5R,6aS)-5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2H-Cyclopenta[b]furan-2-on Tafluprost Impurity 29 Tafluprost Intermediate Prostaglandin Impurity 38 2H-Cyclopenta[b]furan-2-one,5-(benzoyloxy)-4-[(1E)-3,3-diflu (3aR,4R,5R,6aS)-4-((E)-3,3-difluoro-4-phenoxybut-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate 2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-butenyl]hexahydro-, (3,4R,5R,6aS) (3,4R,5R,6aS)-4-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan (3,4R,5R,6aS)-4-((E)-3,3-difluoro-4-phenoxybutan-1-en-1-yl)-hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl benzoate (3,4R,5R,6aS)-5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2H-Cyclopenta[b]furan-2-one Latanoprost Impurity 21 (3,4R,5R,6aS)-4-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate [(3,4R,5R,6aS)-4-(3,3-difluoro-4-phenoxybut-1-enyl)-2-oxo-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] benzoate TF-BF |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 588.3±50.0 °C at 760 mmHg |
| 分子式 | C24H22F2O5 |
| 分子量 | 428.425 |
| 闪点 | 298.1±25.0 °C |
| 精确质量 | 428.143524 |
| PSA | 61.83000 |
| LogP | 4.29 |
| 蒸汽压 | 0.0±1.6 mmHg at 25°C |
| 折射率 | 1.579 |
|
~80%
209861-00-7 |
| 文献:DR.REDDYS LABORATORIES LIMITED; JACKSON, Mark P Patent: WO2013/118058 A1, 2013 ; Location in patent: Page/Page column 8 ; |
|
~%
209861-00-7 |
| 文献:DR.REDDYS LABORATORIES LIMITED; JACKSON, Mark P Patent: WO2013/118058 A1, 2013 ; |
|
~%
209861-00-7 |
| 文献:DR.REDDYS LABORATORIES LIMITED; JACKSON, Mark P Patent: WO2013/118058 A1, 2013 ; |
| 上游产品 3 | |
|---|---|
| 下游产品 1 | |